Biotech's January Catalyst Calendar: FDA Decisions That Could Move Markets
Critical FDA decisions in January 2026 could spark major moves in biotech stocks. Here's your guide to the key dates and companies to watch.
TRENDING TOPICS
1366 articles found for "investing"
Critical FDA decisions in January 2026 could spark major moves in biotech stocks. Here's your guide to the key dates and companies to watch.
The K-shaped economy has split America's retail giants. Walmart gains market share as value-conscious consumers flock to low prices, while Target's premium positioning struggles.
Airlines are doubling down on luxury travelers with new lounges, premium cabins, and the Airbus A321XLR. Inside the class divide reshaping the skies in 2026.
The Russell 2000 is outperforming big tech by nearly 600 basis points as investors rotate into small caps. Here's why 2026 could finally be the year of the small stock.
At 95, legendary investor Warren Buffett has officially retired as CEO of Berkshire Hathaway, ending a 60-year reign that transformed a failing textile company into a $1 trillion conglomerate.
Nvidia's $20 billion deal to license Groq's technology and hire its key engineers represents the largest transaction in AI chip history. Here's what it means for investors.
U.S. spot Bitcoin ETFs posted their worst two-month stretch on record with $4.57 billion in net outflows. Here's what's driving institutional investors toward the exits.
The pan-European STOXX 600 reached record levels on January 2, 2026, led by defense contractors and banking stocks. Here's why European equities may deserve a place in your portfolio.
As Greg Abel takes the helm at Berkshire Hathaway, the conglomerate has slashed its Apple holdings by 75% while making a massive $4.3 billion bet on Alphabet's AI future.
A new study reveals Gen Z investors overwhelmingly prefer cryptocurrency to traditional retirement savings, with 42% owning crypto versus just 11% with a 401(k) or IRA.
The biotech sector staged a stunning recovery in 2025, with the XBI ETF surging 85% from its April bottom. Here's why analysts expect the rally to continue in 2026.
IonQ, Rigetti, and D-Wave have surged over 1,000% on quantum computing hype. But with valuations at 1,000x sales and no commercial breakthroughs, a collapse may be imminent.